{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-090064","form_type":"8-K","ticker":"CYDY","cik":"0001175680","company_name":"CytoDyn Inc.","filed_at":"2022-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.588528+00:00","generated_at":"2026-06-26T13:09:15.760336+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"CytoDyn appoints Karen J. Brunke, Ph.D. as director effective March 27, 2022","bullets":["Dr. Brunke fills the vacancy created by Harish Seethamraju's resignation in December 2021.","She brings over 30 years of biotech experience, currently EVP at Jaguar Health (JAGX).","Board expects to appoint her to Compensation Committee; compensation per nonemployee director policy.","No transactions requiring disclosure under Item 404(a) between Dr. Brunke and the Company."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-090064","json":"https://secwatch.observer/filing/0001193125-22-090064.json","markdown":"https://secwatch.observer/filing/0001193125-22-090064.md","text":"https://secwatch.observer/filing/0001193125-22-090064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175680/000119312522090064/0001193125-22-090064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175680/000119312522090064/d687103d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T13:09:15.760336+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"92374aa519","claim":"Karen J. Brunke was appointed as director at CytoDyn Inc..","evidence_excerpt":"On March 27, 2022, the Board of Directors (the “Board”) of CytoDyn Inc. (the “Company”) approved the appointment of Karen J. Brunke, Ph.D., as a director of the Company, subject to satisfactory completion of a background check.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1175680/000119312522090064/0001193125-22-090064-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}